Evogene and ELEO team up on oral PCSK9 inhibitor discovery
Go back to Evogene and ELEO team up on oral PCSK9 inhibitor discovery| EVOGENE LTD. (NASDAQ: EVGN) | Delayed: 0.51 -0.03 (5.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.54 | 52 Week High | $9.32 | |||
| Open | $0.55 | 52 Week Low | $5.79 | |||
| Day High | $0.55 | P/E | N/A | |||
| Day Low | $0.50 | EPS | $0.00 | |||
| Volume | 157,021 | |||||

